What is Neurocrine Biosciences's income taxes receivable?

Neurocrine Biosciences (NBIX) reported income taxes receivable of $127.70M in Q1 2026.

What does income taxes receivable mean?

Tax refunds or credits owed to the company by government tax agencies.

Income taxes receivable

Neurocrine Biosciences Income taxes receivable increased by 35.9% to $127.70M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionCurrent Assets

CategoryLiquidity

SignalHigher is better

VolatilityModerate

First reportedQ4 2025

Last reportedQ1 2026May 5, 2026

How to read this metric

An increase may indicate overpayment of estimated taxes or the accrual of refundable credits, representing a potential source of near-term cash inflow.

Detailed definition

This represents the amount of income tax overpayments or refundable tax credits that the company expects to recover from...

Peer comparison

Common for large corporations that manage complex tax filings across multiple jurisdictions.

Metric ID: income_taxes_receivable

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$94.00M	$127.70M
QoQ Change	—	+35.9%

Range$94.00M – $127.70M

Income taxes receivable at Other Companies

BiogenBIIB View metric

ViatrisVTRS View metric

Eli LillyLLY View metric

IQVIAIQV View metric

ModernaMRNA View metric

Frequently Asked Questions

What is Neurocrine Biosciences's income taxes receivable?: Neurocrine Biosciences (NBIX) reported income taxes receivable of $127.70M in Q1 2026.
What does income taxes receivable mean?: Tax refunds or credits owed to the company by government tax agencies.